One of the standard features of most articles discussing the options backdating scandal has been the obligatory statement that backdating largely disappeared after the 2002 passage of the Sarbanes-Oxley Act, as a result of the Act’s requirement (in Section 403(a)(2)) that all transactions in the company’s shares involving directors or officers must be documented
The Paulson Committee and Securities Regulation Reform
In an earlier post (here), I commented on the initative of the so-called Committee on Capital Markets Regulation to take a look at the impact of regulation on the competitiveness of the U.S. securities markets in the global marketplace. (The Committee has become known as the Paulson Committee because of the public support
The Pre-IPO Company and D & O Risk
An October 25, 2006 article in the Raleigh, N.C. News and Observer entitled “Voyager Hit by New Lawsuit” (here) provides an interesting example of the kinds of claims and liability exposures that officials at pre-IPO companies can face, particularly where the anticipated IPO fails to launch.
Voyager Pharmaceuticals is a Raleigh, N.C.-based pharmaceutical
Institutional Plaintiffs’ Impact on Securities Litigation
For those of us who must try to understand securities litigation trends, one of the developments worth watching closely has been the impact of institutional plaintiffs (mostly public pension funds) on securities litigation. It has been apparent for some time that cases with institutional lead plaintiffs usually resulted in larger settlements, but the question remained
Tracking Options Backdating
According to news reports (here), Glass Lewis has released an analysis estimating that the options backdating scandal now involves 152 companies and has cost those companies collectively about $10.3 billion. A breakdown of the 152 companies can be found here.
CFO.com reports here that so far over 60 companies have announced accounting
The End of an Era?
According to an October 25, 2006 Washington Post article entitled “End of Enron’s Saga Brings Era to a Close” (here, registration required), the sentencing of former Enron CEO Jeffrey Skilling “closed the book on an era of high profile corporate malfeasance.” Among other things, the Post article reports that “[h]ours after a judge
Developments in Outside Director Liability
As the various corporate scandals have unfolded, one of the concerns has been whether changing laws and attitudes may mean that outside directors face increased exposure to shareholder claims and enforcement actions. (See my prior article on the topic here.) One of the elements of this concern has been the statements of various regulatory
Skilling’s Sentencing
On Monday October 23, 2006, the final chapter in the Enron criminal saga will conclude when Judge Sim Lake sentences former Enron CEO Jeffrey Skilling. Pundits’ estimates of Skilling’s likely sentence range from 20 to 25 years (here). The accumulated anger of the legions of Enron employees and investors seem to require a
Latest Options Backdating Dispatches
The options backdating story has unfolded in successive stages. First, there was the March 18, 2006 Wall Street Journal article (here, registration required) that drew attention to the issue and set off the media frenzy. Then there were the waves of announcements from companies stating that they or regulators were investigating their options
More About Board Turmoil and D & O Risk
In recent weeks, the Hewlett-Packard (H-P) board has struggled to manage the turmoil and adverse publicity from its flawed investigation of media leaks. While the H-P debacle may be the most notorious recent example of board tumult, it is merely one of many instances of problems arising from increased tension inside numerous corporate boardrooms. By